Furthermore, as hyperlipidemia is a risk factor for NAFLD, those with NAFLD have elevated levels of specific lipoproteins like apoB, compared to populations without this liver disease. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.